Wealth Alliance Neurocrine Biosciences Inc Transaction History

Wealth Alliance

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$130.4 - $143.74 $27,384 - $30,185	-210 Reduced 9.87%	1,917 $264,000
Q4 2023 Jan 30, 2024	SELL	$106.07 - $132.76 $1,909 - $2,389	-18 Reduced 0.84%	2,127 $280,000
Q3 2023 Nov 09, 2023	BUY	$94.02 - $117.1 $201,672 - $251,179	2,145 New	2,145 $241,000

625

94.2M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Wealth Alliance, based on Form 13F filings with the SEC.

Stay updated on Wealth Alliance with notifications on news.